Heather Oakervee

4.2k total citations
42 papers, 1.6k citations indexed

About

Heather Oakervee is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Heather Oakervee has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 19 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Heather Oakervee's work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (14 papers) and Hematopoietic Stem Cell Transplantation (12 papers). Heather Oakervee is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (14 papers) and Hematopoietic Stem Cell Transplantation (12 papers). Heather Oakervee collaborates with scholars based in United Kingdom, United States and Japan. Heather Oakervee's co-authors include Jamie Cavenagh, Samir Agrawal, David Taussig, Rakesh Popat, John G. Gribben, Debra M. Lillington, Dominique Bonnet, Farideh Miraki‐Moud, Nicola Curry and Mary Drake and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Heather Oakervee

42 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather Oakervee United Kingdom 19 1.2k 888 639 298 184 42 1.6k
Todd M. Zimmerman United States 28 1.6k 1.3× 1.2k 1.4× 990 1.5× 313 1.1× 219 1.2× 95 2.2k
Alice S. Mims United States 23 802 0.7× 705 0.8× 414 0.6× 261 0.9× 187 1.0× 130 1.5k
Carolina Schinke United States 21 899 0.8× 692 0.8× 662 1.0× 215 0.7× 162 0.9× 142 1.4k
A. John Ashcroft United Kingdom 16 949 0.8× 663 0.7× 913 1.4× 190 0.6× 156 0.8× 23 1.5k
Andrea Freeman United States 12 1.1k 0.9× 787 0.9× 586 0.9× 220 0.7× 221 1.2× 15 1.4k
Anuj Mahindra United States 17 918 0.8× 703 0.8× 477 0.7× 116 0.4× 227 1.2× 56 1.2k
Charlotte Pawlyn United Kingdom 22 1.5k 1.2× 1.3k 1.4× 862 1.3× 156 0.5× 182 1.0× 115 2.0k
Agnieszka Wierzbowska Poland 22 1.5k 1.2× 1.1k 1.3× 483 0.8× 227 0.8× 461 2.5× 108 2.3k
Stefan Kasper Germany 24 395 0.3× 636 0.7× 885 1.4× 448 1.5× 211 1.1× 122 2.0k
Stephen A. Strickland United States 27 1.8k 1.5× 1.4k 1.5× 503 0.8× 139 0.5× 460 2.5× 99 2.4k

Countries citing papers authored by Heather Oakervee

Since Specialization
Citations

This map shows the geographic impact of Heather Oakervee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Oakervee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Oakervee more than expected).

Fields of papers citing papers by Heather Oakervee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Oakervee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Oakervee. The network helps show where Heather Oakervee may publish in the future.

Co-authorship network of co-authors of Heather Oakervee

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Oakervee. A scholar is included among the top collaborators of Heather Oakervee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Oakervee. Heather Oakervee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drake, Mary, Paul Kettle, Michael O’Dwyer, et al.. (2021). How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma. SHILAP Revista de lepidopterología. 3(1). 27–27. 1 indexed citations
2.
Cavenagh, Jamie, Heather Oakervee, Faith E. Davies, et al.. (2017). A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma. British Journal of Cancer. 117(9). 1295–1302. 42 indexed citations
3.
Popat, Rakesh, Sarah Brown, Louise Flanagan, et al.. (2016). Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. The Lancet Haematology. 3(12). e572–e580. 35 indexed citations
4.
Miraki‐Moud, Farideh, Fernando Anjos‐Afonso, Katharine Hodby, et al.. (2013). Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation. Proceedings of the National Academy of Sciences. 110(33). 13576–13581. 108 indexed citations
5.
Dignan, Fiona L., Danielle Greenblatt, M.C. Cox, et al.. (2011). Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplantation. 47(6). 824–830. 52 indexed citations
6.
Taussig, David, Jacques Vargaftig, Farideh Miraki‐Moud, et al.. (2010). Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction. Blood. 115(10). 1976–1984. 262 indexed citations
7.
Stevens, Jane, et al.. (2009). Patterns of recruitment into acute myeloid leukaemia (AML) 15 and outcome for young patients with AML at a single referral centre. British Journal of Haematology. 145(1). 40–44. 6 indexed citations
8.
Popat, Rakesh, Heather Oakervee, Catherine Williams, et al.. (2009). Bortezomib, low‐dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma. British Journal of Haematology. 144(6). 887–894. 37 indexed citations
9.
Taussig, David, Farideh Miraki‐Moud, Fernando Anjos‐Afonso, et al.. (2008). Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 112(3). 568–575. 278 indexed citations
10.
Jüliger, Simone, Takayuki Nakashima, Lenushka Maharaj, et al.. (2008). A Novel Heat Shock Protein (HSP) 90 Inhibitor KW-2478 shows Activity in B-Cell Malignancies in Vitro and in Vivo.. Blood. 112(11). 1625–1625. 3 indexed citations
11.
Basnayake, Kolitha, Colin A. Hutchison, Dia Kamel, et al.. (2008). Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report. Journal of Medical Case Reports. 2(1). 380–380. 16 indexed citations
12.
Popat, Rakesh, Heather Oakervee, Simon Hallam, et al.. (2008). Bortezomib, doxorubicin and dexamethasone (PAD) front‐line treatment of multiple myeloma: updated results after long‐term follow‐up. British Journal of Haematology. 141(4). 512–516. 101 indexed citations
13.
Oakervee, Heather, Rakesh Popat, & Jamie Cavenagh. (2007). Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: Impact on stem cell harvesting and engraftment. Leukemia & lymphoma. 48(10). 1910–1921. 25 indexed citations
14.
Popat, Rakesh, Simon Joel, Heather Oakervee, & Jamie Cavenagh. (2006). Bortezomib for multiple myeloma. Expert Opinion on Pharmacotherapy. 7(10). 1337–1346. 11 indexed citations
15.
Oakervee, Heather, Rakesh Popat, Nicola Curry, et al.. (2005). PAD combination therapy (PS‐341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma. British Journal of Haematology. 129(6). 755–762. 235 indexed citations
16.
Gordon, Anthony, Heather Oakervee, Michael J. Barnett, et al.. (2005). Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care*. Anaesthesia. 60(4). 340–347. 31 indexed citations
17.
Bhattacharyya, Madhumita, et al.. (2005). Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin. Clinical & Laboratory Haematology. 27(5). 331–333. 5 indexed citations
18.
Kaya, Burak, et al.. (2005). Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia. Journal of Clinical Pathology. 58(9). 994–995. 6 indexed citations
19.
Schey, Stephen, Jamie Cavenagh, Roderick J. Johnson, et al.. (2003). An UK myeloma forum phase II study of thalidomide; long term follow-up and recommendations for treatment. Leukemia Research. 27(10). 909–914. 52 indexed citations
20.
Cavenagh, Jamie, et al.. (2002). Thalidomide in multiple myeloma: current status and future prospects. British Journal of Haematology. 120(1). 18–26. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Todd M. Zimmerman Breakdown of academic impact, for papers by Alice S. Mims Breakdown of academic impact, for papers by Carolina Schinke Breakdown of academic impact, for papers by A. John Ashcroft Breakdown of academic impact, for papers by Andrea Freeman Breakdown of academic impact, for papers by Anuj Mahindra Breakdown of academic impact, for papers by Charlotte Pawlyn Breakdown of academic impact, for papers by Agnieszka Wierzbowska Breakdown of academic impact, for papers by Stefan Kasper Breakdown of academic impact, for papers by Stephen A. Strickland
Rankless by CCL
2026